日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus

利用感染性增强的纤维嵌合溶瘤腺病毒对化疗耐药性胰腺癌进行实验性病毒疗法

Kaliberov, S A; Kaliberova, L N; Buchsbaum, D J; Curiel, D T

Molecular targeted approaches for treatment of pancreatic cancer

胰腺癌的分子靶向治疗方法

Huang, Z Q; Saluja, A K; Dudeja, V; Vickers, S M; Buchsbaum, D J

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

一项I期研究评估了抗表皮生长因子受体(EGFR)抗体西妥昔单抗作为放射增敏剂联合放化疗治疗局部晚期胰腺癌的作用

Arnoletti, J P; Frolov, A; Eloubeidi, M; Keene, K; Posey, J; Wood, T; Greeno, Edward; Jhala, N; Varadarajulu, S; Russo, S; Christein, J; Oster, R; Buchsbaum, D J; Vickers, S M

Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation

采用表达组织金属蛋白酶抑制剂-2的复制型腺病毒联合放化疗治疗头颈部鳞状细胞癌

McNally, L R; Rosenthal, E L; Zhang, W; Buchsbaum, D J

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

CRAdRGDflt-IL24病毒疗法联合化疗治疗实验性胶质瘤

Kaliberova L N, Krendelchtchikova V, Harmon D K, Stockard C R, Petersen A S, Markert J M, Gillespie G Y, Grizzle W E, Buchsbaum D J, Kaliberov S A

Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model

在小鼠异种移植模型中,通过同时靶向人IL13和EGF受体,基因工程设计一种更有效的抗胰腺癌药物。

Vallera, D A; Stish, B J; Shu, Y; Chen, H; Saluja, A; Buchsbaum, D J; Vickers, S M